OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer
Qi Zhao, Feng Wang, Yan‐Xing Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Qi Zhao, Feng Wang, Yan‐Xing Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Prognostic genome and transcriptome signatures in colorectal cancers
Luís Nunes, Fuqiang Li, Meizhen Wu, et al.
Nature (2024) Vol. 633, Iss. 8028, pp. 137-146
Open Access | Times Cited: 24
Luís Nunes, Fuqiang Li, Meizhen Wu, et al.
Nature (2024) Vol. 633, Iss. 8028, pp. 137-146
Open Access | Times Cited: 24
Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
Tian-Hang Yu, Y Ding, Sophia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Tian-Hang Yu, Y Ding, Sophia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 16
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 16
Transcriptomic subtyping of gastrointestinal malignancies
Tim R. de Back, Sander R. van Hooff, Dirkje W. Sommeijer, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 842-856
Open Access | Times Cited: 7
Tim R. de Back, Sander R. van Hooff, Dirkje W. Sommeijer, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 842-856
Open Access | Times Cited: 7
Prediction of Clinical Precision Chemotherapy by Patient‐Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases
Hang Sun, Lejia Sun, Xindi Ke, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 15
Hang Sun, Lejia Sun, Xindi Ke, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 15
Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer
Kunqiao Hong, Qian Yang, Haisen Yin, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Kunqiao Hong, Qian Yang, Haisen Yin, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer
Shixiang Wang, Chen‐Yi Wu, Ming-Ming He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Shixiang Wang, Chen‐Yi Wu, Ming-Ming He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Identification of clinicopathological‐specific driver gene and genetic subtyping of colorectal cancer
Jianjiong Li, Chunnian Wang, Changshun Yang, et al.
Cancer Science (2025)
Open Access
Jianjiong Li, Chunnian Wang, Changshun Yang, et al.
Cancer Science (2025)
Open Access
Omics technologies as powerful approaches to unravel colorectal cancer complexity and improve its management
Zaynab Fatfat, Marwa Hussein, Maamoun Fatfat, et al.
Molecules and Cells (2025), pp. 100200-100200
Open Access
Zaynab Fatfat, Marwa Hussein, Maamoun Fatfat, et al.
Molecules and Cells (2025), pp. 100200-100200
Open Access
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Plasma proteomic and polygenic profiling improve risk stratification and personalized screening for colorectal cancer
Jing Sun, Yue Liu, Jianhui Zhao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Jing Sun, Yue Liu, Jianhui Zhao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Comprehensive assessment of computational methods for cancer immunoediting
Shengyuan He, Shangqin Sun, Kun Liu, et al.
Cell Reports Methods (2025) Vol. 5, Iss. 3, pp. 101006-101006
Open Access
Shengyuan He, Shangqin Sun, Kun Liu, et al.
Cell Reports Methods (2025) Vol. 5, Iss. 3, pp. 101006-101006
Open Access
Cytogenetic signatures favoring metastatic organotropism in colorectal cancer
Monika M. Golas, Bastian Gunawan, Angelika Gutenberg, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Monika M. Golas, Bastian Gunawan, Angelika Gutenberg, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The lysosomal trafficking regulator “LYST”: an 80-year traffic jam
M Turner, Jingru Che, Gabriel Mirhaidari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
M Turner, Jingru Che, Gabriel Mirhaidari, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
DNA mismatch repair protects the genome from oxygen-induced replicative mutagenesis
Rita Lózsa, Eszter Németh, Judit Z. Gervai, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 20, pp. 11040-11055
Open Access | Times Cited: 5
Rita Lózsa, Eszter Németh, Judit Z. Gervai, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 20, pp. 11040-11055
Open Access | Times Cited: 5
Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
Yinqiang Liu, Jin Duan, Fujun Zhang, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 147-163
Open Access | Times Cited: 4
Yinqiang Liu, Jin Duan, Fujun Zhang, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 147-163
Open Access | Times Cited: 4
Prognostic whole-genome and transcriptome signatures in colorectal cancers
Luís Nunes, Fuqiang Li, Meizhen Wu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Luís Nunes, Fuqiang Li, Meizhen Wu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Computational Quantification of Cancer Immunoediting
Kun Liu, Shengyuan He, Shangqin Sun, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 9, pp. 1159-1167
Closed Access | Times Cited: 4
Kun Liu, Shengyuan He, Shangqin Sun, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 9, pp. 1159-1167
Closed Access | Times Cited: 4
Mitochondrial DNA Haplogroups and SNPs: Risk Factors in Multiple Cancers Based on a Cross-Tumor Analysis in Chinese Population
Dongbo Chen, Zeyu Yan, Qing Yuan, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 3, pp. 381-388
Closed Access | Times Cited: 1
Dongbo Chen, Zeyu Yan, Qing Yuan, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 3, pp. 381-388
Closed Access | Times Cited: 1
Advancing Frontiers in Colorectal Cancer: Exploring Novel Insights and Emerging Trends in Research and Therapy
Amer Al Ali
Advancements in Life Sciences (2024) Vol. 11, Iss. 4, pp. 714-714
Open Access | Times Cited: 1
Amer Al Ali
Advancements in Life Sciences (2024) Vol. 11, Iss. 4, pp. 714-714
Open Access | Times Cited: 1
The tissue and circulating cell‐free DNA‐derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer
Qingjian Chen, Yu‐Hong Xu, Shiyang Kang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 1
Qingjian Chen, Yu‐Hong Xu, Shiyang Kang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 1
Genetic and microenvironmental evolution of colorectal liver metastases under chemotherapy
Min Shi, Yingxi Yang, Na Huang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 12, pp. 101838-101838
Closed Access | Times Cited: 1
Min Shi, Yingxi Yang, Na Huang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 12, pp. 101838-101838
Closed Access | Times Cited: 1
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer
Miao‐Zhen Qiu, Yuxian Bai, Jufeng Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Miao‐Zhen Qiu, Yuxian Bai, Jufeng Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Mutational signature of mtDNA confers mechanistic insight into oxidative metabolism remodeling in colorectal cancer
Wenjie Guo, Yang Liu, Xiaoying Ji, et al.
Theranostics (2022) Vol. 13, Iss. 1, pp. 324-338
Open Access | Times Cited: 7
Wenjie Guo, Yang Liu, Xiaoying Ji, et al.
Theranostics (2022) Vol. 13, Iss. 1, pp. 324-338
Open Access | Times Cited: 7
Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer
Wen Zhou, Ming-Ming He, Feng Wang, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Wen Zhou, Ming-Ming He, Feng Wang, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
